RGC

REGENCELL BIOSCIENCE HLDGS L

RGC·G7487R100·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist

RGC (REGENCELL BIOSCIENCE HLDGS L) is held by 22 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($10.6M), Marex Group Ltd ($803,588), Vident Advisory, LLC ($752,423). Net institutional sentiment: Bullish.

22
Holders
(1 Elite)
$15.6M
Total Value
73% (22)
Consensus
16 buying - 6 selling
13F: Insider & Congress:
RGCSmart Money Verdict
View all
Held by 22 funds
1 elite
Who's Trading
ActivistR(Regencell (BVI) Limited86.2%Jul 11, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
415,569(+0.6%)$10.6M0.0%-65.62%
28
New
31,600$803,5880.0%-75.49%
34
Decreased
29,588(-1.2%)$752,4230.0%-69.00%
0
Increased
26,613(+2.3%)$676,7690.0%-66.49%
25
Increased
23,885(+31.2%)$607,3960.0%-74.51%
31
Decreased
20,078(-6.3%)$510,5840.0%-65.95%
0
Increased
17,172(+591x)$436,6840.0%-75.48%
26
New
11,851$301,3710.0%-75.49%
36
New
9,903$251,8330.0%-75.49%
32
New
8,596$218,5960.0%-75.49%
32
New
8,595$218,5710.0%-75.49%
32
Increased
4,957(+1.9%)$126,0570.0%-65.03%
15
New
2,231$56,7340.0%-75.49%
29
New
845$19,7140.0%-75.49%
29
New
760$19,3270.0%-75.49%
28
New
354$9,0020.0%-75.49%
26
Unchanged
301$7,6540.0%-74.32%
0
Decreased
201(-55.1%)$6,7780.0%-67.93%
0
Unchanged
227$5,7710.0%-65.88%
0
New
69$2,0000.0%-75.49%
17

Showing 1-20 of 24

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used